Skip to content

Matrilysin Expression in Different Stages of Colorectal Tumors

Matrilysin Expression in Different Stages of Colorectal Tumors

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01570452
Acronym
MMP7
Enrollment
38
Registered
2012-04-04
Start date
2005-09-30
Completion date
2012-02-29
Last updated
2012-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer Stage 0, Colorectal Cancer Stage I, Colorectal Cancer Stage II, Colorectal Cancer Stage III, Colorectal Cancer Stage IV

Keywords

matrilysin, MMP-7, colorectal cancer, adenoma, lymph nodes

Brief summary

Matrix metalloproteinases (MMPs) have been shown to be involved in cancer biology. Significant expression of MMP-7 (matrilysin) in colorectal cancer is mainly associated with metastatic disease even though it is expressed in most tumor states. Our purpose is to analyse MMP-7 in bowel and lymph nodes of different tumor stages and to evaluate its expression as a potential biomarker of cancer disease in patients surgically treated for benign and malignant colorectal tumors. Tumoral tissue, lymph nodes and serum samples from recruited Patients plus serum samples from healthy volunteers are analysed for matrilysin expression by histology, immunohistochemistry, ELISA and Western blotting. If Matrilysin increases with increasing dysplasia and cancer disease stage in tumor tissue as well as in the regional lymph nodes it might be used as a complement in investigating suspected locally advanced cancer.

Interventions

PROCEDUREcolonic or colorectal resection

standard laparotomic resection of colon-rectum including right hemicolectomy, left hemicolectomy, sigmoidectomy, anterior resection

Sponsors

University of Roma La Sapienza
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 83 Years
Healthy volunteers
Yes

Inclusion criteria

* benign colonic neoplasm not suitable for endoscopic treatment, * malignant colonic neoplasm with indication to primary surgical treatment

Exclusion criteria

* neo-adjuvant radiotherapy, * chemo-radiotherapy, * language problems and withdrawal of consent

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026